Role of Peroxiredoxin 1 Induced by Epstein-Barr Virus Infection in Nasopharyngeal Carcinoma

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Nasopharyngeal carcinoma (NPC) is linked to Epstein-Barr Virus (EBV) infection, common in Southern China.
• The precise role of EBV in NPC pathogenesis remains incompletely understood.
• This study investigates the latent EBV gene LMP2A and its potential association with peroxiredoxin 1 (PRDX1) in EBV-positive NPC.

Purpose of the Study:

• To determine the relationship between LMP2A and PRDX1 in EBV-positive NPC.
• To elucidate the molecular mechanisms by which LMP2A influences NPC cell behavior.
• To assess the potential of LMP2A as a therapeutic target.

Main Methods:

• Compared mRNA and protein expression of LMP2A, PRDX1, and beta-catenin in patient samples and NPC cell lines (EBV-negative NP69, EBV-positive C666-1).
• Assessed reactive oxygen species (ROS) levels using fluorescence microscopy and flow cytometry.
• Utilized reverse transcription polymerase chain reaction and western blotting to investigate signaling pathways influenced by LMP2A.

Main Results:

• EBV-infected NPC samples and cell lines showed elevated LMP2A expression and high ROS levels.
• LMP2A expression promoted cell viability and growth by regulating gene expression.
• LMP2A induced the expression of PRDX1, beta-catenin, cyclin B1, and cyclin D1.

Conclusions:

• LMP2A regulates PRDX1 and beta-catenin expression in NPC cells.
• LMP2A influences cell cycle progression through related gene expression.
• LMP2A represents a potential therapeutic target for inhibiting NPC progression in EBV-infected individuals.